Dr. Gottlieb is a uveitis & medical retina specialist at the University of Ottawa Eye Institute. 

She is Assistant Professor, Residency Program Director and Vice-Chair of Education in the Department of Ophthalmology, Faculty of Medicine, University of Ottawa.

Following undergraduate studies at the University of Waterloo, medical school at McMaster University and residency in ophthalmology at Dalhousie University, Dr. Gottlieb completed a two-year Fellowship in uveitis and medical retina at the National Eye Institute, NIH, in Bethesda, MD, USA with a certificate of recognition for her work studying ocular Toxoplasmosis in the Laboratory of Molecular Parasitology at the NIAID. Her current research interests include the dexamethasone intravitreal implant for the treatment of posterior uveitis and uveitic CME, and the mfERG in Plaquenil retinopathy.

Dr. Gottlieb received the Department of Ophthalmology clinical teaching award in 2019. She is a member of the Female Physician Leadership Committee of The Ottawa Hospital. Her roles with the COS include the MOC committee, Advocacy committee and the adjudication committee for the Awards for Excellence in Research of the COS Annual Meeting.

Dr. Gottlieb enjoys her role as a consultant to the department of ophthalmology at the Children’s Hospital of Eastern Ontario, where she co-manages the care of children with uveitis alongside a multidisciplinary team. She is currently working with a national group of uveitis specialists led by the Canadian Rheumatology Association, who together will create a set of Canadian guidelines on the management of JIA-associated uveitis.

Financial disclosure: Dr. Gottlieb has/had an affiliation (financial or otherwise) with a commercial organization:

1. AbbVie
2. Allergan
3. Novartis
4. Bayer
5. Viatris